Author, Subjects, Keywords

Cited Author

 
 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » Malaysian Journals
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top Journal Cited
 » Top Article Cited
 » Journal Citation Statistics
 » Usage Since Sept 2007


 
 
 

Login | Create Account

Pseudomonas Aeruginosa: Epidemiology of Bactereremia and Antimicrobial Susceptibility Pattern in a Teaching Hospital in Kuala Lumpur

Nadeem S.R., and Rina K., and Hamimah H., and Savithi, D.P., (2006) Pseudomonas Aeruginosa: Epidemiology of Bactereremia and Antimicrobial Susceptibility Pattern in a Teaching Hospital in Kuala Lumpur. Journal of the University of Malaya Medical Centre (JUMMEC), 9 (1). pp. 14-19. ISSN 1823-7339

[img]
Preview
PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
81Kb

Official URL: http://jummec.um.edu.my

Affiliations

University of Malaya. Faculty of Medicine. Dept. of Medical Microbiology

Abstract

A cross-sectional study of 109 patients with Pseudomonas aeruginosa bacteremia from the University of Malaya Medical Centre (UMMC) in the years 2000 and 2001 was conducted to describe epidemiological features, underlying diseases, possible source of infection, early mortality among patients as well as the antibiotic susceptibility pattern of patients’ isolates. Further analysis of the 87 patient records that were available revealed that the mean age was 48.5 years (SD ± 25.1). Fifty-two per cent of cases were male and 48% female. Seventy-nine per cent of infections were nosocomially acquired, 33% of bacteremias were polymicrobial, 47% of patients had a continuous bladder drainage catheter (CBD) in situ, 33% had a central venous catheter (CVL) present at the time of bacteremia and 30% were ventilated. Sixty-eight per cent of patients had an underlying immunosuppressed state and 26% had undergone surgery involving general anesthesia in the week prior to isolating P. aeruginosa. Among the 23 patients with early mortality, 61% were on inappropriate antimicrobials. Most of the patients’ isolates were sensitive to imipenem (86%), ciprofloxacin (81%), ceftazidime (79%), gentamicin (78%) and cefoperazone (77%). Among the community acquired strains, however, there was 100% sensitivity to imipenem, ceftazidime, cefoperazone and ciprofloxacin.

Item Type:Journal
Keywords:Pseudomonas aeruginosa, bacteremia, antimicrobial susceptibility
Subjects:R Medicine, Dentistry, Pharmacy, Nursing
ID Code:6370

1. Aliaga L, Mediavilla JD, Cobo F. A clinical index predicting mortality with Pseudomonas aeruginosa bacteremia. J Med Microbiol 2002; 51: 615-9.

2. Bodey GP, Bolivar R, Fainstein V, et al. Infections caused by Pseudomonas aeruginosa. Rev Infect Dis 1983; 5: 279-313.

3. Pollack M. Pseudomonas aeruginosa. In: Mandell GL, Bennett JE,Dolin R, (eds.),Mandell,Douglas and Bennett’s Principles and Practice of Infectious Diseases. 5th edition. Philadelphia: Churchill Livingstone; 2000. pp.2310-35.

4. Kovacs K, Paterson DL, Yu VL. Antimicrobial therapy for Pseudomonas aeruginosa. Available at http://www. medscape.com/viewarticle/417355.

5. Foca M, Jakob K,Whittier S, et al. Endemic Pseudomonas aeruginosa infection in a neonatal intensive care unit. N Engl J Med 2000; 343: 695-700.

6. Weinstein MP,Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997; 24: 584-602.

7. National Consensus for Clinical Laboratory Standards (NCCLS). Performance standards for Antimicrobial Disk Susceptibility Tests – Sixth Edition: 1999.Approved Standard M2-A6 NCCLS,Wayne, PA.

8. National Consensus for Clinical Laboratory Standards 2000. Performance Standards for antimicrobial susceptibility testing. Tenth informational supplement M100-S10.Wayne, PA: NCCLS.

9. Lopez Dupla M, Martinez JA, Vidal F, et al. Clinical characteristics of breakthrough bacteremia: a survey of 392 episodes. J. Intern Med 2005; 258:172-80.

10 Whitecar JP Jr, Luna M, Bodey GP. Pseudomonas bacteremia in patients with malignant diseases.Am J Med Sci 1970; 260: 216-23.

11. Forkner CE Jr, Frei E 3rd, Edgcomb JH, et al. Pseudomonas septicemia; observations on twenty-three cases. Am J Med 1958; 25: 877-89.

12. Aliaga L, Mediavilla JD, Llosa J, et al. Clinical significance of polymicrobial versus monomicrobial bacteremia involving Pseudomonas aeruginosa. Eur J Clin MicrobiolInfect Dis 2000; 19: 871-4.

13. Vidal F, Mensa J, Almela M, et al. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment.Analysis of 189 episodes.Arch Intern Med 1996; 156: 2121-6.

14. Gallagher PG, Watanakunakorn C. Pseudomonas bacteremia in a community teaching hospital, 1980-1984.Rev Infect Dis 1989; 11: 846-52.

15. Hilf M, Yu VL, Sharp J, et al. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med 1989; 87: 540-6.

16. Mallolas J, Gatell JM, Miro JM, et al. Epidemiological characteristics and factors influencing the outcome of Pseudomonas aeruginosa bacteremia. Rev Infect Dis 1990; 12: 718-9.

17. Mallolas J, Gatell JM, Miro JM, et al. Analysis of prognostic factors in 274 consecutive episodes of Pseudomonas aeruginosa bacteremia. Antibiot Chemother 1991; 44:106-14.

18. Kuikka A,Valtonen VV. Factors associated with improved outcome of Pseudomonas aeruginosa bacteremia in a Finnish university hospital. Eur J Clin Microbiol InfectDis 1998; 17: 701-8.

Repository Staff Only: item control page
 
 
 
 
 
 
© Copyright 2007 MyAIS Faculty of Computer Science and Information Technology, University of Malaya – All Rights Reserved. Malaysian Abstracting and Indexing System is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.